Evidence map›Paper›PMID 34681941›Full record

ReviewInternational journal of molecular sciences2021

The Dopaminergic Control of Movement-Evolutionary Considerations.

Juan Pérez-Fernández, Marta Barandela, Cecilia Jiménez-López

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Evolutionary innovations in the primate dopaminergic system.Current opinion in genetics & development · 2024
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Juan Pérez-FernándezCenter for Biomedical Research (CINBIO), Neurocircuits Group, Department of Functional Biology and Health Sciences, Campus Universitario Lagoas, Marcosende, Universidade de Vigo, 36310 Vigo, Spain.ORCID 0000-0001-7109-951X
Marta BarandelaCenter for Biomedical Research (CINBIO), Neurocircuits Group, Department of Functional Biology and Health Sciences, Campus Universitario Lagoas, Marcosende, Universidade de Vigo, 36310 Vigo, Spain.
Cecilia Jiménez-LópezCenter for Biomedical Research (CINBIO), Neurocircuits Group, Department of Functional Biology and Health Sciences, Campus Universitario Lagoas, Marcosende, Universidade de Vigo, 36310 Vigo, Spain.ORCID 0000-0003-1565-2506
Universidade de Vigo · ES

Funding

Ramón y Cajal grant RYC2018-024053-I funded by MCIN/AEI/ 10.13039/501100011033 and by "ESF Investing in your Future" Xunta de Galicia (ED431B 2021/04).Xunta de Galicia ED431B 2021/04
6 · The paper itself

Abstract

Dopamine is likely the most studied modulatory neurotransmitter, in great part due to characteristic motor deficits in Parkinson's disease that arise after the degeneration of the dopaminergic neurons in the substantia nigra

Indexed as

AnimalsCardiotonic AgentsDopamineDopaminergic NeuronsMotor ActivityNeural PathwaysReceptors, Dopamine D1Receptors, Dopamine D2Cardiotonic AgentsDopamineReceptors, Dopamine D1Receptors, Dopamine D2aversionbasal gangliadopamine receptorslampreyposterior tuberculumrewardsalienceSNcVTA

Identifiers

PMID34681941
PMCPMC8541398
OpenAlexW3206908106

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.